Form 4 for LRCX Lam Research
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-04 · accession 0001469469-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-05 | 2026-03-04 | LRCX | Bettinger Douglas R | CFO, EVP | M - OptEx | $65.80 | +77.8K | 1.13M | +7% | +$5.12M |
| D | 2026-03-05 | 2026-03-04 | LRCX | Bettinger Douglas R | CFO, EVP | S - Sale+OE | $224.03 | -50.1K | 1.08M | -4% | -$11.21M |
| DM | 2026-03-05 | 2026-03-04 | LRCX | Bettinger Douglas R | CFO, EVP | M - OptEx | $0.00 | -77.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-04 | M | A | 51,270 | $49.09 | 1,105,282 | D | — | — | (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 2 | Common | Common Stock | 2026-03-04 | M | A | 26,480 | $98.15 | 1,131,762 | D | — | — | (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 3 | Common | Common Stock | 2026-03-04 | S | D | 50,057 | $224.03 | 1,081,705 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $223.90 to $224.39, inclusive (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2026-03-04 | M | D | 26,480 | $0.00 | 13,240 | D | $98.15 · — to 2031-03-01 | 26,480 Common Stock | (F4) The stock options will become exercisable in three equal installments on 03/01/2025, 03/01/2026, and 03/01/2027. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2026-03-04 | M | D | 51,270 | $0.00 | 0 | D | $49.09 · — to 2030-03-01 | 51,270 Common Stock | (F3) The stock options will become exercisable in three equal installments on 03/01/2024, 03/01/2025 and 03/01/2026. |